Adventist Healthcare
Home » News » News Detail


San Nuclear Medicine physician Dr Edwin Szeto on 2GB discussing the new Theranostics service at the San

The San has recently welcomed to its Radiology and Nuclear medicine department a new service – Theranostics.

Theranostics is a personalised approach to treating cancer using both therapy and diagnostics. The first therapy that will be used by the service is for men with advanced prostate cancer called Lutetium-177 Prostate Specific Membrane Antigen aka “Lutetium-PSMA” therapy. This therapy is used when the disease has spread, and other treatments have failed or been poorly tolerated.
The theranostics service at San Radiology & Nuclear Medicine commenced in March 2021, with a dedicated theranostics area within the imaging department which will enable the dedicated team to treat up to three patients at any one time in a safe and comfortable environment.
San Nuclear Medicine Physician Dr Edwin Szeto joins John Stanley to discuss this new service.
Click here to listen to the podcast. 

Back to News